Skip to main content
SpringerLink
Log in

Über den Einfluß von Ergotamin auf die LSD-„Psychose“ beim Menschen

  • Kurze Originalmitteilungen
  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Summary

Pretreatment with ergotamine prior to LSD-experiments inhibited central sympathetic activity. The psychic symptoms of LSD on the other hand were prolonged or intensified. We feel that the psychic LSD symptoms were not due to activation of the central sympathetic nervous system. The prolongation of the psychic LSD-symptoms after pretreatment with ergotamine were explained on the basis of competitive inhibition of LSD-degradation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Isbell, H., R. E. Belleville, H. E. Eraser, A. Wikler and C. R. Logan: Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication. Arch. Neurol. Psychiat. (Chic.) 76, 468–478 (1956).

    Google Scholar 

  • —, C. R. Logan and E. J. Miner: Studies on lysergic acid diethylamide (LSD-25). II. Attempts to attenuate the LSD-reaction in man by pretreatment with neurohumoral blocking agents. Arch. Neurol. Psychiat. (Chic.) 81, 20–27 (1959).

    Google Scholar 

  • Rothlin, E.: Pharmacology of lysergic acid diethylamide and some of its related compounds. J. Pharm. Pharmacol. 9, 569–587 (1957).

    Google Scholar 

  • —, A. Cerletti, H. Konzett, W. R. Schalch u. M. Taeschler: Zentrale vegetative LSD-Effekte. Experientia (Basel) 12, 154 (1956).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biochemische Abteilung und Abteilung für Psychopathologie und Psychotherapie, Deutsche Forschungsanstalt für Psychiatrie -Max Planck-Institut, Kraepelinstr. 2, 8 München 23

    N. Matussek & A. Halbach

Authors
  1. N. Matussek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Halbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Wir danken der Sandoz AG, Nürnberg, für die großzügige Überlassung der Versuchsmengen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matussek, N., Halbach, A. Über den Einfluß von Ergotamin auf die LSD-„Psychose“ beim Menschen. Psychopharmacologia 5, 158–160 (1964). https://doi.org/10.1007/BF00413052

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00413052

Search

Navigation